JP2005504016A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504016A5
JP2005504016A5 JP2003507101A JP2003507101A JP2005504016A5 JP 2005504016 A5 JP2005504016 A5 JP 2005504016A5 JP 2003507101 A JP2003507101 A JP 2003507101A JP 2003507101 A JP2003507101 A JP 2003507101A JP 2005504016 A5 JP2005504016 A5 JP 2005504016A5
Authority
JP
Japan
Prior art keywords
glutamate
subtypes
uptake
action
chatton
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003507101A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504016A (ja
JP4542336B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2002/006286 external-priority patent/WO2003000698A1/en
Publication of JP2005504016A publication Critical patent/JP2005504016A/ja
Publication of JP2005504016A5 publication Critical patent/JP2005504016A5/ja
Application granted granted Critical
Publication of JP4542336B2 publication Critical patent/JP4542336B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003507101A 2001-06-22 2002-06-24 ベンゼン環上にアミノ基を有するβ−ベンジルオキシアスパラギン酸誘導体 Expired - Lifetime JP4542336B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001190022 2001-06-22
PCT/JP2002/006286 WO2003000698A1 (en) 2001-06-22 2002-06-24 β-BENZYLOXYASPARTATE DERIVATIVES WITH AMINO GROUP ON BENZENE RING

Publications (3)

Publication Number Publication Date
JP2005504016A JP2005504016A (ja) 2005-02-10
JP2005504016A5 true JP2005504016A5 (https=) 2006-01-05
JP4542336B2 JP4542336B2 (ja) 2010-09-15

Family

ID=19028851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003507101A Expired - Lifetime JP4542336B2 (ja) 2001-06-22 2002-06-24 ベンゼン環上にアミノ基を有するβ−ベンジルオキシアスパラギン酸誘導体

Country Status (4)

Country Link
US (2) US7247652B2 (https=)
EP (1) EP1397370B1 (https=)
JP (1) JP4542336B2 (https=)
WO (1) WO2003000698A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7622499B2 (en) * 2003-05-30 2009-11-24 Suntory Holdings Limited β-Benzyloxyaspartate derivatives with photosensitive groups
EP1732864B1 (en) * 2004-03-18 2013-12-25 Suntory Holdings Limited Radiolabeled 3-[3- (benzoyl-amido) benzyloxy]aspartic acid derivative and method of producing the same
WO2006047251A2 (en) * 2004-10-21 2006-05-04 The University Of Montana 3-alkylaryl aspartate compounds and their use for selective enhancement of synaptic transmission
JP4008446B2 (ja) * 2004-12-27 2007-11-14 サントリー株式会社 ベンゼン環上に二置換基を有するβ−ベンジルオキシアスパラギン酸誘導体
WO2011104307A2 (en) * 2010-02-25 2011-09-01 Graffinity Pharmaceuticals Gmbh Ligands for antibody purification by affinity chromatography
CN103134893B (zh) * 2013-01-25 2014-12-03 峨眉山天梁星制药有限公司 一种3-叔丁基二甲硅氧基戊二酸酐的高效液相色谱分析法
US10625280B2 (en) 2014-10-06 2020-04-21 Tel Fsi, Inc. Apparatus for spraying cryogenic fluids
US10014191B2 (en) 2014-10-06 2018-07-03 Tel Fsi, Inc. Systems and methods for treating substrates with cryogenic fluid mixtures
JP6690915B2 (ja) 2014-10-06 2020-04-28 ティーイーエル マニュファクチュアリング アンド エンジニアリング オブ アメリカ，インコーポレイテッド 極低温流体混合物で基板を処理するシステムおよび方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576323A (en) * 1993-12-03 1996-11-19 Eli Lilly And Company Excitatory amino acid receptor antagonists
JP3936418B2 (ja) * 1996-10-25 2007-06-27 サントリー株式会社 β−ヒドロキシアスパラギン酸誘導体

Similar Documents

Publication Publication Date Title
JP2005504016A5 (https=)
CN110248926A (zh) Lsd1抑制剂及其制备方法和应用
WO2010033444A8 (en) Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
UA100367C2 (uk) Спосіб одержання мемантину і його гідрохлориду
WO2009016460A3 (en) Pyrazole compounds and their use as raf inhibitors
WO2007019255A3 (en) Salts of vildagliptin
WO2003084936A8 (en) Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
SE0302324D0 (sv) Novel compounds
WO2006030291A3 (en) Radiofluorinated peptides
UA99447C2 (ru) Способ получения силденафила
SE0302323D0 (sv) Novel compounds
NO20065719L (no) I det vesentlige rene 2-{[2-(2-metylamino-pyrimidin-4-yl)-1H-indol-5-karbonyl]-amlno}-3-(fenylpyridin-2-yl-amino)-propionsyre som en IkB kinaseinhibitor.
Fülep et al. New highly potent GABA uptake inhibitors selective for GAT-1 and GAT-3 derived from (R)-and (S)-proline and homologous pyrrolidine-2-alkanoic acids
WO2007075964A8 (en) Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery
AR049681A1 (es) Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas
CA2476022A1 (en) A process for preparing a phenylalanine derivative and intermediates thereof
ZA200705889B (en) New 3-phenylpropionic acid derivatives and their use as PPAR-GAMMA receptor ligands
BRPI0508392A (pt) materiais e métodos para tratar distúrbios de coagulação
WO2006051314A3 (en) Guanidine derivatives as inhibitors of ddah
JP2009055850A5 (https=)
JP2009523791A5 (https=)
MX2010004235A (es) Piperidinas tri-sustituidas.
JP2005526695A5 (https=)
CA2629339A1 (en) Pyrazolo[4,3-d]pyrimidin-5-yl) derivative used as pde5 inhibitors